Gemfields Group Valuation
Is 5PH undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 5PH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 5PH (€0.1) is trading below our estimate of fair value (€5.16)
Significantly Below Fair Value: 5PH is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 5PH?
Key metric: As 5PH is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 5PH's PS Ratio? | |
|---|---|
| PS Ratio | 0.6x |
| Sales | US$236.36m |
| Market Cap | US$135.45m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.1x |
| Enterprise Value/EBITDA | 4.8x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 5PH's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.6x | ||
2HRA H&R GmbH KGaA | 0.1x | 2.7% | €127.3m |
NTG Nabaltec | 0.6x | 4.7% | €122.8m |
UZU Uzin Utz | 0.5x | 4.3% | €244.1m |
BNN BRAIN Biotech | 1.2x | 8.5% | €70.6m |
5PH Gemfields Group | 0.6x | 23.7% | €2.5b |
Price-To-Sales vs Peers: 5PH is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (0.6x).
Price to Sales Ratio vs Industry
How does 5PH's PS Ratio compare vs other companies in the European Metals and Mining Industry?
| 35 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 35 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: 5PH is good value based on its Price-To-Sales Ratio (0.6x) compared to the European Metals and Mining industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is 5PH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.6x |
| Fair PS Ratio | 0.8x |
Price-To-Sales vs Fair Ratio: 5PH is good value based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (0.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Central Asia Metals
UK£276.3m
Operates as a base metals producer.
9C3
UK£1.88
7D
1.1%
1Y
-3.6%
Compañía de Minas BuenaventuraA
US$3.1b
Engages in the exploration, development, construction, and operation of mineral processing business.
MBU
US$11.40
7D
-0.9%
1Y
37.3%
Ecora Resources
UK£159.3m
Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.
HGR
UK£0.77
7D
7.7%
1Y
-26.9%